Ceritinib
Last Updated: 04/28/2026
Need to find the closest trial?
Sort By Distance
Save trials for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
2 clinical trials found
A Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by a Randomized Controlled Trial of Standard Immunotherapy With or Without DFMO Followed by DFMO Maintenance for Subjects With Newly Diagnosed High-Risk Neuroblastoma
Who is this study for: Patients with Neuroblastoma
Enrollment Status: Recruiting
Publish Date: February 20, 2026
Intervention Type: Drug
Study Drugs: Ceritinib, Dasatinib, Sorafenib, Vorinostat, DFMO
Study Phase: Phase 2
Summary: A prospective open label, multicenter study to evaluate the feasibility and acute toxicity of using molecularly guided therapy in combination with standard therapy followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for Subjects with Newly Diagnosed High-Risk Neuroblastoma.
Population Pharmacokinetics, Effectiveness and Safety of Antineoplastic Drugs in Elderly Patients
Enrollment Status: Recruiting
Publish Date: July 20, 2022
Intervention Type: Drug
Summary: The purpose is to study the population pharmacokinetics, effectiveness and safety of antineoplastic drugs (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib, Imatinib, Lapatinib, etc) in elderly patients and recommend optimized dosage regimens.
Showing 1-2 of 2
Last Updated: 04/28/2026